H

Hana Pharm Co Ltd
KRX:293480

Watchlist Manager
Hana Pharm Co Ltd
KRX:293480
Watchlist
Price: 11 130 KRW 1.92% Market Closed
Market Cap: 192.5B KRW
Have any thoughts about
Hana Pharm Co Ltd?
Write Note

Hana Pharm Co Ltd
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hana Pharm Co Ltd
Other Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
H
Hana Pharm Co Ltd
KRX:293480
Other Equity
â‚©520
CAGR 3-Years
35%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Other Equity
â‚©104B
CAGR 3-Years
-13%
CAGR 5-Years
3%
CAGR 10-Years
3%
SK Biopharmaceuticals Co Ltd
KRX:326030
Other Equity
â‚©8B
CAGR 3-Years
58%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Other Equity
-â‚©19.7B
CAGR 3-Years
-203%
CAGR 5-Years
-30%
CAGR 10-Years
-23%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Other Equity
â‚©58.8B
CAGR 3-Years
159%
CAGR 5-Years
79%
CAGR 10-Years
34%
C
Celltrion Pharm Inc
KOSDAQ:068760
Other Equity
â‚©13B
CAGR 3-Years
24%
CAGR 5-Years
27%
CAGR 10-Years
13%
No Stocks Found

Hana Pharm Co Ltd
Glance View

Market Cap
192.5B KRW
Industry
Pharmaceuticals

Hana Pharm Co., Ltd. engages in the research, development, and manufacture of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 657 full-time employees. The company went IPO on 2018-10-02. The company’s main products include cardiovascular drugs involves hypertension and hyperlipidemia medicines, as well as blood circulation improvement drugs; analgesics for severe pain and anesthetics for surgery and sedation; as well as gastrointestinal drugs such as peptic ulcer treatment and antispasmodics. The firm also provides antibiotics, dermatology analgesics, antipyretics and anti-inflammatory drugs.

Intrinsic Value
18 041.77 KRW
Undervaluation 38%
Intrinsic Value
Price
H

See Also

What is Hana Pharm Co Ltd's Other Equity?
Other Equity
520 KRW

Based on the financial report for Sep 30, 2024, Hana Pharm Co Ltd's Other Equity amounts to 520 KRW.

What is Hana Pharm Co Ltd's Other Equity growth rate?
Other Equity CAGR 3Y
35%

The average annual Other Equity growth rates for Hana Pharm Co Ltd have been 35% over the past three years .

Back to Top